Michael Cruse - Net Worth and Insider Trading
Michael Cruse Net Worth
The estimated net worth of Michael Cruse is at least $82,737 dollars as of 2024-11-05. Michael Cruse is the COO of Reneo Pharmaceuticals Inc and owns about 4,546 shares of Reneo Pharmaceuticals Inc (RPHM) stock worth over $82,737. Details can be seen in Michael Cruse's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Michael Cruse has not made any transactions after 2022-09-01 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Michael Cruse
Michael Cruse Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Michael Cruse owns 1 companies in total, including Reneo Pharmaceuticals Inc (RPHM) .
Click here to see the complete history of Michael Cruse’s form 4 insider trades.
Insider Ownership Summary of Michael Cruse
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| RPHM | Reneo Pharmaceuticals Inc | 2022-09-01 | Senior VP & Corporate Operation |
Michael Cruse Latest Holdings Summary
Michael Cruse currently owns a total of 1 stock. Michael Cruse owns 4,546 shares of Reneo Pharmaceuticals Inc (RPHM) as of September 1, 2022, with a value of $82,737.
Latest Holdings of Michael Cruse
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| RPHM | Reneo Pharmaceuticals Inc | 2022-09-01 | 4,546 | 18.20 | 82,737 |
Holding Weightings of Michael Cruse
Michael Cruse Form 4 Trading Tracker
According to the SEC Form 4 filings, Michael Cruse has made a total of 3 transactions in Reneo Pharmaceuticals Inc (RPHM) over the past 5 years, including 3 buys and 0 sells. The most-recent trade in Reneo Pharmaceuticals Inc is the acquisition of 750 shares on September 1, 2022, which cost Michael Cruse around $25,425.
Insider Trading History of Michael Cruse
- 1
Michael Cruse Trading Performance
GuruFocus tracks the stock performance after each of Michael Cruse's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Michael Cruse is -20.22%. GuruFocus also compares Michael Cruse's trading performance to market benchmark return within the same time period. The performance of stocks bought by Michael Cruse within 3 months outperforms 1 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Michael Cruse's insider trading performs compared to the benchmark.
Performance of Michael Cruse
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 8.26 | | | | | |
| Relative Return to S&P 500(%) | 14.88 | | | | | |
Michael Cruse Ownership Network
Ownership Network List of Michael Cruse
Ownership Network Relation of Michael Cruse
Michael Cruse Owned Company Details
What does Reneo Pharmaceuticals Inc do?
Who are the key executives at Reneo Pharmaceuticals Inc?
Michael Cruse is the Senior VP & Corporate Operation of Reneo Pharmaceuticals Inc. Other key executives at Reneo Pharmaceuticals Inc include Chief Development Officer Ashley Hall , 10 percent owner Novo Holdings A/s , and VP of Finance & Administration Jennifer Lam .
Reneo Pharmaceuticals Inc (RPHM) Insider Trades Summary
Over the past 18 months, Michael Cruse made no insider transaction in Reneo Pharmaceuticals Inc (RPHM). Other recent insider transactions involving Reneo Pharmaceuticals Inc (RPHM) include a net purchase of 1,199,482 shares made by Braden Michael Leonard , a net purchase of 125,000 shares made by Niall O'donnell , and a net sale of 100,000 shares made by Novo Holdings A/s .
In summary, during the past 3 months, insiders sold 0 shares of Reneo Pharmaceuticals Inc (RPHM) in total and bought 78,520 shares, with a net purchase of 78,520 shares. During the past 18 months, 11,563 shares of Reneo Pharmaceuticals Inc (RPHM) were sold and 132,448 shares were bought by its insiders, resulting in a net purchase of 120,886 shares.
Reneo Pharmaceuticals Inc (RPHM)'s detailed insider trading history can be found in Insider Trading Tracker table.
Reneo Pharmaceuticals Inc Insider Transactions
Michael Cruse Mailing Address
Above is the net worth, insider trading, and ownership report for Michael Cruse. You might contact Michael Cruse via mailing address: C/o Reneo Pharmaceuticals, Inc., 12230 El Camino Real, Suite 230, San Diego Ca 92130.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
